Evaluating multi-cancer early detection tests: an argument for the outcome of recurrence-updated stage

The advent of multi-cancer early detection (MCED) tests has the potential to revolutionise the diagnosis of cancer, improving patient outcomes through early diagnosis and increased use of curative therapies. The ongoing NHS-Galleri trial is evaluating an MCED test developed by GRAIL, and is using as...

Descripción completa

Detalles Bibliográficos
Autores principales: Callister, Matthew E. J., Crosbie, Emma J., Crosbie, Philip A. J., Robbins, Hilary A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Perspective
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10575849/
https://www.ncbi.nlm.nih.gov/pubmed/37726480
http://dx.doi.org/10.1038/s41416-023-02434-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10575849/
https://www.ncbi.nlm.nih.gov/pubmed/37726480
http://dx.doi.org/10.1038/s41416-023-02434-4

Ejemplares similares